Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr;49(4):1196-201.
doi: 10.1128/JCM.02233-10. Epub 2011 Jan 19.

Analysis of emergence of quinolone-resistant gonococci in Greece by combined use of Neisseria gonorrhoeae multiantigen sequence typing and multilocus sequence typing

Affiliations

Analysis of emergence of quinolone-resistant gonococci in Greece by combined use of Neisseria gonorrhoeae multiantigen sequence typing and multilocus sequence typing

Angeliki Mavroidi et al. J Clin Microbiol. 2011 Apr.

Abstract

The prevalence of quinolone-resistant Neisseria gonorrhoeae (QRNG) in Greece remained low from 1997 to 2003 but increased dramatically from 11% to 56% between 2004 and 2007. N. gonorrhoeae multiantigen sequence typing (NG-MAST) and multilocus sequence typing (MLST) were used to investigate trends in quinolone resistance from 1997 to 2007 and explore the origins of the recent increase in QRNG. We characterized 295 QRNG isolates from the study period and 233 quinolone-susceptible (QS) gonococci from 2004 and 2005, when the rapid increase in QRNG occurred. From 1997 to 1999, an outbreak of QRNG was due to the dissemination of isolates of serovar Arst that belonged to two closely related genotypes. Few QRNG isolates, of diverse genotypes, were present between 2001 and 2003, whereas the sharp increase in QRNG from 2004 onwards was due to the appearance of serovar Bropyst isolates of several major NG-MAST sequence type (STs) that previously had not been identified in Greece. These isolates were shown by MLST to be variants of a single multiply antibiotic-resistant QRNG strain (ST1901) that appeared in Greece and rapidly diversified into 31 NG-MAST STs. There were no isolates of MLST ST1901 or any of the 31 NG-MAST STs among QS isolates from 2004 and 2005 or among 8 representatives of multiresistant but quinolone-susceptible serovar Bropyst isolates circulating in Greece during the 1990 s, supporting the view that the recent increase in QRNG was due to importation of a QRNG strain(s) of MLST ST1901 into Greece. Recently, multiresistant QRNG isolates of ST1901 with reduced susceptibility to the newer cephalosporins have appeared in Greece.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Number of isolates of gonococci of each NG-MAST ST submitted each year. The color coding for the major NG-MAST STs in the data set is shown at the bottom. Isolates of minor NG-MAST STs are grouped together and shown as white in the histogram.
Fig. 2.
Fig. 2.
Number of isolates of gonococci of each MLST ST submitted each year. The color coding for the major MLST STs in the data set is shown at the bottom (NG-MAST STs are shown in parentheses). Isolates of minor MLST STs are grouped together and shown as white in the histogram.
Fig. 3.
Fig. 3.
Most likely evolutionary pathways between NG-MAST STs. Predicted pathways were obtained using statistical parsimony as implemented in the TCS program (3). The prevalence of isolates of NG-MAST STs is shown by the size of the ovals and the square. The latter indicates the predicted ancestral ST. Nucleotide substitutions between connected STs are indicated.

Similar articles

Cited by

References

    1. Bennett J. S., et al. 2007. Species status of Neisseria gonorrhoeae: evolutionary and epidemiological inferences from multilocus sequence typing. BMC Biol. 5:35. - PMC - PubMed
    1. Choudhury B., et al. 2006. Identification of individuals with gonorrhoea within sexual networks: a population-based study. Lancet 368:139–146 - PubMed
    1. Clement M., Posada D., Crandall K. A. 2000. TCS: a computer program to estimate gene genealogies. Mol. Ecol. 9:1657–1660 - PubMed
    1. Farhi D., Dupin N. 2006. The rise of fluoroquinolone resistant Neisseria gonorrhoeae. Implications for treatment guidelines. Swiss Med. Wkly. 138:223–224 - PubMed
    1. Goold P. C., Bignell C. J. 2006. No way back for quinolones in the treatment of gonorrhoea. Sex. Transm. Infect. 82:225–226 - PMC - PubMed

Publication types

MeSH terms